 effect ursodiol efficaci safeti extracorpor shock-wav lithotripsi gallston dornier nation biliari lithotripsi studi background treatment gallston extracorpor shock-wav lithotripsi bile acid ursodiol gallston fragment studi valu agent method center symptomat patient radioluc gallston mm diamet oral cholecystographi ursodiol placebo month week lithotripsi result stone percent patient fragment equal mm diamet percent basi intention-to-treat analysi patient percent ursodiol percent placebo gallbladd free stone month radioluc solitari stone mm diamet percent patient ursodiol percent placebo free stone month biliari pain mild percent patient percent free stone month advers event differ frequenc group percent ursodiol group percent placebo group sever biliari pain percent patient acut cholecyst percent acut pancreat percent sphincterotomi percent cholecystectomi percent conclus extracorpor shock-wav lithotripsi ursodiol effect treatment symptomat gallston safe treatment effect solitari multipl stone radioluc stone stone